Company / Depreciation & Amortization
Arbutus Biopharma Corp Depreciation & Amortization History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.0M
FY2020
5-year range
-
FY2016-FY2020
Trend
-7.0%
vs FY2019
Sector context
#102 of 168
Health Care
What the data says
At $2M, Arbutus Biopharma Corp's depreciation & amortization ranks #67 of 168 in the Health Care sector.
Based on SEC 10-K filings.
$2M in FY2020 with a 3-year CAGR of +0.0%.
Remained stable around $2M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#67 of 168 in Health CareTop 39% of 168This company $2.0M Sector average $212.9M
▼
-99.0% below sector average
Key checks
Key Insights
- 3-year CAGR of +0.0%, indicating consistent growth.
- In FY2020, depreciation & amortization decreased 7.0% year-over-year.
- Ranks #102 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $2.0M | -7.0% |
| FY2019 | $2.2M | +7.6% |
| FY2018 | $2.0M | +0.0% |
| FY2017 | $2.0M | +85.6% |
| FY2016 | $1.1M | +85.4% |
As of FY2020 · SEC 10-K · Updated Jul 2, 2026